AMICUS THERAPEUTICS, INC. — Director's Dealing 2020

Mar 9, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2020-03-05

Reporting Person: Campbell Bradley L (Director, Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-05	Common Stock	M	2500	$5.96	Acquired	358014	Direct
2020-03-05	Common Stock	S	2500	$10.01	Disposed	355514	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-05	Stock Options (right to buy)	$5.96	M	2500	Disposed	2021-01-19	Common Stock (2500)	Direct

Footnotes

F1: The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2: All of the options were fully vested and exercisable as of March 5, 2020.